Nawid Albinger

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Staphylococcus Aureus

Top Venues

Bone marrow transplantation

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Nawid Albinger, Sabine Müller, Julia Kostyra, Jan Kuska, Sarah Mertlitz, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone marrow transplantation 59 (4) (2024)
Nawid Albinger, Sabine Müller, Julia Kostyra, Jan Kuska, Sarah Mertlitz, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone marrow transplantation 59 (4) (2024)
Nawid Albinger, Sabine Müller, Julia Kostyra, Jan Kuska, Sarah Mertlitz, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone marrow transplantation (2024)
Nawid Albinger, Sabine Müller, Julia Kostyra, Jan Kuska, Sarah Mertlitz, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone marrow transplantation 59 (4) (2024)
Nawid Albinger, Sabine Müller, Julia Kostyra, Jan Kuska, Sarah Mertlitz, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone marrow transplantation 59 (4) (2024)
Nawid Albinger, Rita Pfeifer, Marcus Nitsche, Sarah Mertlitz, Julia Campe, Katja Stein, Hermann Kreyenberg, Ralf Schubert, Melissa Quadflieg, Dina Schneider, Michael W M Kühn, Olaf Penack, Congcong Zhang, Nina Möker, Evelyn Ullrich
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia. Blood cancer journal 12 (4) (2022)
Nawid Albinger, Jessica Hartmann, Evelyn Ullrich
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene therapy 28 (9) (2021)